Journal
/
/
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Journal JoVE
Immunologie et infection
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Immunologie et infection
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
DOI:

07:44 min

August 12, 2021

, , , , , , ,

Chapitres

  • 00:05Introduction
  • 00:50Production and Evaluation of the HiBiT-RBD Bioreporter
  • 03:47Detecting Anti-RBD Antibody with a Fast and Sensitive Assay
  • 04:53High-Throughput Detection of the SARS-CoV-2-Specific Antibodies from Patient Serum Samples
  • 06:05Results: SARS-CoV-2 Antibody Detection Using HiBiT-Based Bioreporter
  • 07:06Conclusion

Summary

Traduction automatique

The outlined protocol describes the procedure for producing the HiBiT-receptor-binding domain protein complex and its application for fast and sensitive detection of SARS-CoV-2 antibodies.

Vidéos Connexes

Read Article